| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84,2 M € | -8.0% | 91,5 M € | +0.1% | 91,5 M € | -10.0% | 101,6 M € | +6.4% | 95,5 M € | +40.3% | 68,1 M € | — | ||
| EBITDA | 1,2 M € | -61.2% | 3,1 M € | +305.5% | 765,2 k € | -69.0% | 2,5 M € | -25.3% | 3,3 M € | +565.4% | 497,1 k € | -43.9% | 886,7 k € | |
| Operating profit | 1,0 M € | -65.0% | 3,0 M € | +352.3% | 663,0 k € | -71.9% | 2,4 M € | -24.5% | 3,1 M € | +686.7% | 397,3 k € | -55.2% | 886,7 k € | |
| Profit/loss | 1,7 M € | +1.5% | 1,7 M € | +12.0% | 1,5 M € | +21.3% | 1,3 M € | +280.1% | 328,9 k € | +119.4% | -1,7 M € | -178.9% | -607,0 k € | |
| Equity | 29,2 M € | +6.3% | 27,5 M € | +6.6% | 25,8 M € | +6.2% | 24,3 M € | +5.4% | 23,0 M € | +14.2% | 20,2 M € | +3527.2% | -588,5 k € | |
| Total assets | 45,9 M € | -14.8% | 53,8 M € | -13.6% | 62,3 M € | +15.0% | 54,2 M € | +18.9% | 45,6 M € | -17.7% | 55,4 M € | +108.0% | 26,6 M € | |
| Cash | 258,8 k € | -5.6% | 274,1 k € | +2708.9% | 9,8 k € | +163.4% | 3,7 k € | -85.0% | 24,8 k € | -99.9% | 18,8 M € | +1413.5% | 1,2 M € | |
| Debts | 16,2 M € | -37.2% | 25,8 M € | -28.5% | 36,1 M € | +23.7% | 29,1 M € | +33.1% | 21,9 M € | -36.9% | 34,7 M € | +27.5% | 27,2 M € | |
| Staff | 64,8 | 64,2 | 63,5 | 60,6 | 67,8 | 61,9 | 29,6 | |||||||
Private limited company · Machelen (Brab.) · incorporated on 26/01/2018 · 64,8 ETP
Private limited company profitable and well capitalised. Cash position declining (-5.6%).
Solid counterparty for a standard engagement.
O&M Halyard Belgium is a Private limited company incorporated in 2018. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 64,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette